Doctors take a dig at pharmacist-only drug proposal
They argue that additional training will not mitigate the risk
10th July 2018
Patients will be at risk if pharmacists are allowed to supply sildenafil without a prescription, says the AMA in response to a downscheduling proposal.
In yet another dig at pharmacists, the AMA says it has no confidence that additional training will “mitigate” the risk to patient safety.
Although pharmacist-direct supply has been successfully introduced in New Zealand, the AMA’s submission to the Advisory Committee on Medicines Scheduling (ASMS) questions the ability of Australian pharmacists to comply with quality use